Reese Pharmaceutical Begins Second Phase of Campaign to Promote CRC Screening

Reese Pharmaceutical has begun the second phase of its campaign aimed at encouraging families to discuss their family history of colorectal cancer (CRC) during holiday gatherings. This initiative is part of a broader effort to raise awareness about the growing accessibility of CRC screening tests and promote proactive preventive measures.

The Growing Concern of Colorectal Cancer

Colorectal cancer has become a significant health concern in the United States. Despite being one of the most preventable forms of cancer, many Americans remain unaware of their risk factors or the importance of early screening. The alarming rise in new diagnoses, particularly among young adults, underscores the urgent need for increased awareness and accessible screening options.

A Troubling Spike in Younger Diagnoses

A recent report by the American Cancer Society highlights a troubling spike in new colon and rectal cancer diagnoses among young adults under 55. This trend is nearly double the number of cases from a decade ago, making it crucial for younger individuals to be proactive about their health.

The Importance of Family History

Knowing one's family history is crucial when it comes to CRC. Studies have shown that individuals with an immediate family member diagnosed with CRC are between 2 and 4 times more likely to develop the disease themselves. However, a staggering 80% of US adults are unaware if a first-degree relative (parent, sibling, or child) has been diagnosed with CRC.

The Role of Family Discussions

Reese Pharmaceutical's initiative encourages families to use holiday gatherings as an opportunity to discuss their family history of CRC. By fostering open communication, families can better understand their individual risks and take necessary steps towards prevention.

How to Discuss CRC with Your Family

• Start the Conversation: Begin by asking about any family members who have been diagnosed with CRC.
• Be Open-Minded: Listen carefully to the information shared, and be open to discussing your own risk factors.
• Seek Resources: Provide resources like the #MyCRChistory campaign, which encourages sharing family histories on social media, to help others understand their potential risks.

The Growing Accessibility of Screening Tests

Reese Pharmaceutical is highlighting the growing accessibility of CRC screening tests, particularly through its innovative at-home screening option, ColoTest.

What is ColoTest?

ColoTest is an over-the-counter (OTC) Fecal Immunochemical Test (FIT) that identifies the presence of hidden blood in the stool, a key warning sign for CRC and other gastrointestinal disorders. The test is simple to use, requiring only one stool sample and offering instant results. This non-invasive screening method makes it easy for anyone to access without the need for lab analysis or dietary restrictions.

Features of ColoTest

• Convenience: Users collect the sample at home and receive their results in as little as one minute.
• Affordability: The suggested retail price of $19.99 makes it an inexpensive option for anyone to purchase out-of-pocket.
• Accessibility: Available at a growing number of pharmacies, ColoTest offers a discreet alternative for those who may feel adverse to traditional screening methods like colonoscopies.

The Impact of Early Detection

Early detection is critical in preventing the spread of CRC. According to studies, immunochemical test screening can reduce the overall risk of colon cancer death by 33%. By making screening more accessible and convenient, tests like ColoTest can facilitate earlier detection and improved outcomes.

Why Early Detection Matters

• Preventable Deaths: 90% of colon cancer-related deaths are thought to be preventable if caught early.
• Increased Survival Rates: Early detection significantly improves survival rates and reduces the severity of treatment needed.

Conclusion

Reese Pharmaceutical's second phase campaign is a timely reminder of the importance of discussing CRC family history and utilizing readily available screening tools like ColoTest. As the US continues to grapple with rising CRC diagnoses, it is crucial for families to be proactive about their health and for healthcare providers to offer accessible screening options. By fostering awareness and facilitating early detection, we can work towards reducing the alarming rates of this preventable disease.

---

References:

1. Reese Pharmaceutical Begins Second Phase of Campaign to Promote CRC Screening - https://www.prnewswire.com/news-releases/reese-pharmaceutical-begins-second-phase-of-campaign-to-promote-crc-screening-302280087.html
2. Dangerous Gap in Colon Cancer Risk Awareness Highlighted by Survey - https://www.insideprecisionmedicine.com/topics/oncology/dangerous-gap-in-colon-cancer-risk-awareness-highlighted-by-survey/
3. Majority of US Adults Unclear About Family History of CRC - https://www.ajmc.com/view/majority-of-us-adults-unclear-about-family-history-of-crc
4. Reese Pharmaceutical Launches New At-Home Colon Cancer Screening Test - https://www.prnewswire.com/news-releases/reese-pharmaceutical-launches-new-at-home-colon-cancer-screening-test-302070648.html
5. Education Is Crucial to Close Gaps in Colorectal Cancer Risk Awareness - https://www.drugtopics.com/view/education-is-crucial-to-close-gaps-in-colorectal-cancer-risk-awareness